Anuh Pharma to acquire API manufacturing facility from Vanquest Pharma for Rs 72.9 Cr
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 0.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Anuh Pharma has signed an Asset Transfer Agreement to purchase the manufacturing facility of Vanquest Pharma Private Limited located at Tarapur, Maharashtra. The deal includes land, building, plant and machinery for API and Intermediates manufacturing, valued at Rs 72.90 Crore excluding taxes. The acquisition is expected to add 525 MTPA to the company's production capacity. It is an all-cash deal, not a related party transaction, and no shares will be issued.
Capacity expansion of 525 MTPA in API manufacturing via Rs 72.9 Cr cash deal. Positive for long-term production growth.